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Mitochondrial biogenesis is a complex process. It necessitates the contribution of both the nuclear and the mitochondrial genomes
and therefore crosstalk between the nucleus and mitochondria. It is now well established that cellular mitochondrial content can
vary according to a number of stimuli and physiological states in eukaryotes. The knowledge of the actors and signals regulating
the mitochondrial biogenesis is thus of high importance. The cellular redox state has been considered for a long time as a key
element in the regulation of various processes. In this paper, we report the involvement of the oxidative stress in the regulation of
some actors of mitochondrial biogenesis.
1.Introduction
Mitochondria are organelles that have critical functions in
eukaryotic cells. Besides their well-known involvement in
energy and intermediary metabolism (i.e., ATP synthesis,
thermoregulation, heme biosynthesis), mitochondria also
play a crucial role in both calcium homeostasis and apop-
tosis. Mitochondrial dysfunction has been associated with
numerous pathologies including neurodegenerative diseases
[1], diabetes [2], and aging [3, 4]. ATP synthesis by mito-
chondria is mostly generated through oxidative phosphory-
lation (OXPHOS) (Figures 1 and 2). Enzymatic complexes of
the mitochondrial respiratory chain couple the oxidation of
reducing agents such as NADH and FADH2 to proton extru-
siontowardtheintermembranespace.Duetothelowproton
permeabilityoftheinnermitochondrialmembrane,thispro-
ton extrusion results in the establishment of an electrochem-
ical potential diﬀerence in protons across this membrane.
This proton electrochemical potential diﬀerence is, in turn,
used for ATP synthesis by the F0F1-ATP synthase complexes.
Mitochondria (and chloroplasts) are unique among
eukaryotic extranuclear organelles in that they contain their
owngenome(mtDNA).Inmammaliancells,mtDNAisacir-
cularmolecule,whichencodesfor13mRNAs,22tRNAs,and
2rRNAs. All 13mRNAs encode subunits of the OXPHOS.
However, mitochondria are genetically semiautonomous in
that they rely strongly on the nuclear genome for their
biological function. Indeed, all the remaining mitochondrial
proteins, including protein machineries involved in mtDNA
replication, transcription, and translation, are encoded by
the nuclear genome (Figures 1 and 2).
Consequently, mitochondrial biogenesis is a highly reg-
ulated process that involves the coordinated expression of
two distinct genomes. This represents an important ﬁeld of
research notably because it has been well established in a
wide range of cell types that mitochondrial content within
the cell can vary massively depending on the physiological
state[5,6].Forexample,adecreaseinmitochondrialcontent
has been described in numerous pathologies such as type 2
diabetes[7].Thesignalsandactorsinvolvedintheregulation
of mitochondrial biogenesis are thus of high importance.
Some of these pathologies are also associated with an oxida-
tive stress, which raises the question of a possible regulation
of mitochondrial biogenesis by the cellular redox state that
would include ROS levels and glutathione redox state.
In this paper, we focus on some actors of mitochondrial
biogenesis—the increase of the mitochondrial enzymatic
content—at the transcriptional level in both mammalian2 International Journal of Cell Biology
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Figure 1: The mammalian oxidative phosphorylations (OXPHOS) system. Depicted are the four respiratory complexes (I–IV), electron
carriers coenzyme Q and cytochrome c, the ATP synthase complex, the ADP/ATP carrier (ANC); and the phosphate carrier (PiC). Arrows at
complexes I, III, and IV illustrate the proton pumping to the intermembrane space. Indicated are the number of complex subunits encoded
by mitochondrial (mtDNA) and nuclear (nDNA) genomes.
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Figure 2: The Saccharomyces cerevisiae oxidative phosphorylations (OXPHOS) system. The main diﬀerences with the mammalian OXPHOS
system are the absence of complex I that is substituted by external and internal NADH dehydrogenases, and the presence of D, L-lactate
dehydrogenases, which transfer electrons directly to cytochrome c. Indicated are the number of protein subunits encoded by mitochondrial
(mtDNA) and nuclear (nDNA) genomes.
cells and the yeast Saccharomyces cerevisiae and on their
regulation by the cellular redox state.
2. Modulation of the Mitochondrial Content
inMammalian Cells
2.1.Overview. Oneofthebestillustrationsofthevariationof
thecellularmitochondrialcontentistheadaptationtoenergy
demand[6].Intheskeletalmuscle,inthe1960s,experiments
have demonstrated an increase in the number and the size of
mitochondria associated with an increase in the activity of
mitochondrial marker enzymes in response to exercise [8, 9].
Twenty years later, chronic contractile activity produced by
electrical stimulation was shown to increase mRNA levels
encoding both nuclear and mitochondrial gene products
[10]. These modiﬁcations are part of the phenomenon of
exercise-induced muscle plasticity [11, 12]a n da r ep r e s u m -
ably an adaption in order to adequately match ATP synthesis
to ATP consumption by the contractile activity.
Proliferation of mitochondria also occurs during adap-
tive thermogenesis in brown fat during cold exposure. This
proliferation coincides with an increase in the expression of
UCP-1,anuncouplingproteinthatdissipatestheprotongra-
dient,leadingtoanincreaseinmitochondrialrespirationand
to heat production [13–15].
2.2. Transcription Factors. Nuclear respiratory factors (NRF-
1 and NRF-2) were the ﬁrst identiﬁed nuclear transcription
factors governing respiratory gene expression in mammalian
cells. NRF-1 was discovered when studying the regulation of
the cytochrome c encoding gene [16, 17]. This protein binds
toDNAasahomodimerandfunctionsasapositiveregulator
of gene transcription. Inactivation of NRF-1 results in early
embryonic lethality, pointing out its essential function [18].
NRF-2 was identiﬁed by the analysis of the regulation of
cytochrome c oxidase (COX) subunits encoding genes [19].
It is a complex of ﬁve subunits that shares some target genes
with NRF-1. Both NRF-1 and NRF-2 are well known toInternational Journal of Cell Biology 3
regulate the transcription of many respiratory genes, that is,
subunits of complex I, complex II, complex III, COX and
ATP synthase, genes encoding proteins involved in mtDNA
transcription and replication, as well as genes encoding
proteins involved in mitochondrial protein import [17, 20–
23]. Peroxisome proliferator-associated receptors (PPARα,
PPARβ,P P A R γ)a n dE R R α are nuclear hormone receptors
associated with mitochondrial metabolism. These proteins
act as heterodimers and seem to coordinate the expression of
genes involved in both fatty acid oxidation and the respira-
tory chain [24–26].
ThePGC-1familyofcoactivators(PGC-1α,PGC-1β,and
PRC) plays a central role in the transcriptional regulation of
mitochondrial biogenesis. PGC-1α was primarily identiﬁed
as a key actor of adaptative thermogenesis [27]. PGC-1β and
PRC were discovered through research of sequence similarity
to PGC-1α [28, 29]. These coactivators act as coordinators
of the activity of numerous transcription factors involved
in the mitochondrial biogenesis process. Indeed, the PGC-1
proteins, through binding to other transcription factors such
as NRF-1, PPARs, and ERRα, regulate their activity and are
involved in an increase in the expression of transcription
factors like NRF-1 and NRF-2 [30]. Overexpression of
PGC-1α or PGC-1β in cultured cells and transgenic mice
results in an increase of cellular mitochondrial content
[30, 31]. Overexpression in the skeletal muscle induces the
conversion to oxidative type muscle ﬁbers [32, 33]. These
results strengthen the importance of the PGC-1 family in
mitochondrial biogenesis.
2.3. Regulation of Mitochondrial Biogenesis by the Oxidative
Stress. Mitochondria play an important role in the cellular
redox homeostasis due to their main function—that is,
oxidation of reduced NADH and FADH2—but also through
theirinvolvementinROSmetabolism.Indeed,mitochondria
are considered as one of the main sites of ROS production in
the cell [34]. Considered for a long time as toxic byproducts
of oxidative metabolism, ROS are now also considered as
signaling molecules, which mediate redox regulation of mul-
tiple processes such as cell proliferation, diﬀerentiation and
apoptosis [34, 35]. Moreover, a regulation of transcription
factors involved in mitochondrial biogenesis by oxidative
stress has been reported (see the following).
In the late 1990s, an increase in the expression level of
mitochondrial proteins mRNAs by oxidative stress was
reported. Indeed, the addition of antimycin A—a well-
known inhibitor of respiratory chain complex III which
increasesmitochondrialROSproduction—tohumanﬁbrob-
lasts, at a concentration partially inhibiting the cellular res-
piratory, rate led to an increase in cytochrome c1 and
cytochrome b mRNA levels [36]. In accordance with this
study, another team showed that addition of hydrogen
peroxide (H2O2) to lung ﬁbroblasts led to an increase in
the expression of the transcription factor NRF-1, which is
involved in mitochondrial biogenesis [37]. Moreover, lipo-
polysaccharide-inducedoxidativedamageleadstotheupreg-
ulation of NRF-1 and NRF-2 and the redox regulation of
NRF-1 binding to target promoters is supposed to be
mediated through Akt-dependent phosphorylation [38].
St-Pierre et al. [39] have shown that treatment of mouse
embryonic cells with H2O2, increases PGC-1α and PGC-1β
mRNA levels. Previously, several studies showed that PGC-
1α and PGC-1β regulate the expression of genes encoding
enzymes involved in the ROS defense system, that is, catalase
andsuperoxidedismutases(SODs)[40–42].Moreover,PGC-
1αexpressionisimportantforresistancetooxidativedamage
increase, neurodegeneration, and apoptotic cell death [39,
41]. Thus, those results depict a process where there is a
tight link between the biogenesis of a main ROS source
production, that is, mitochondria, and the anti-ROS system.
Furthermore, PGC-1α induction by oxidative stress is partly
mediated by binding of the cAMP responsive element
binding protein (CREB) in the PGC-1α promoter [39].
In skeletal muscle cells, data provided by the Hood team
d e s c r i b e daR O S - m e d i a t e dr e g u l a t i o no fP G C - 1 α transcrip-
tion [43]. Indeed, treatment of C2C12 cells with H2O2
resulted in an increase in PGC-1α mRNA that was prevented
by pretreatment of these cells with an antioxidant: N-acetyl-
L-cysteine (NAC). In this paper, the induction of PGC-1α
seemed to depend on the activation of the AMP-activated
protein kinase (AMPK) by H2O2. That activation increased
the DNA binding activity of the transcription factor USF1
to the PGC-1α promoter, resulting in an increase in PGC-1α
expression. This work is one of the numerous in vitro and
in vivo studies related to the highly debated question of the
relationships between skeletal muscle, oxidative stress, and
physical exercise. Since the 1980s, a stimulus role for skeletal
muscle adaptation to exercise has been suggested [44]. In
recent years, diﬀerent groups reported that oral administra-
tion of antioxidants prevents the exercise-induced adapta-
tion of muscle mitochondria probably through preventing
the induction of transcription factors such as PGC-1α
[45, 46]. Thus, ROS produced during exercise could stim-
ulate mitochondrial biogenesis. However, contradictory
results have also been provided about the inhibitory eﬀect
of antioxidant addition [47, 48] and this research area is still
a strong matter of debate [49, 50].
Diabetes consists in a group of metabolic diseases char-
acterized by defects in the control of glucose and insulin
homeostasis, which are a major public health issue. Type 2
diabetes, the most widespread type of diabetes, is known
to be associated with alterations in mitochondrial density
and mitochondrial dysfunctions in the skeletal muscles of
patients [2, 51]. Transcriptomic proﬁle analysis of type 2
diabetes patients revealed a reduced expression level of genes
encoding proteins involved in the OXPHOS system [52, 53].
Hyperglycemia is known to increase intracellular ROS levels.
Thisissupposedtooccurviaseveralmechanisms[54],oneof
them being an hyperpolarization of the mitochondrial inner
membrane-favorable conditions for ROS production by the
mitochondrial respiratory chain [55]—due to impairment
in the regulatory capacity of the mitochondrial respiratory
chain. Bonnard et al. showed that in hyperglycemic and
hyperlipidemic mice, an increase in muscle ROS production
is associated with mitochondrial alterations and a decrease
in the expression of PGC1-α mRNA and some of its target
genes. In a model of hyperglycemia-associated oxidative
stress (streptozotocin treated mice), NAC treatment restores4 International Journal of Cell Biology
mitochondrial density and structure [56]. In conclusion,
this study suggests that hyperglycemia and hyperlipidemia-
induced ROS production in skeletal muscle leads to mito-
chondrial dysfunction due to a decrease in the expression
of PGC1-α and its target genes. Although these results seem
contradictory if we compare them to the Hood team’s, they
might be reconciled through the physiological state of the
cell. Indeed, downregulation of AMPK activity has been
shown in animal models of insulin resistance, high fat feed-
ing, and glucose infusion [57, 58]. Thus, energetic param-
eters should be considered to interpret the consequences of
the oxidative stress on mitochondrial biogenesis.
3. Modulation of Mitochondrial Content in
the Yeast Saccharomyces cerevisiae
3.1. Overview. The budding yeast Saccharomyces cerevisiae
is the unicellular eukaryotic microorganism with the best
annotated complete genome sequence. It has been widely
used to study molecular mechanisms underlying diverse bio-
logical aspects such as mitochondrial functions. Indeed,
whenyeastcellsaregrownonnonfermentablecarbonsource,
that is, lactate or ethanol, mitochondria are the unique
sourceofATP.Asstatedpreviously,cellsadapttotheirenergy
needs by adjusting their mitochondrial enzymatic content
resulting in a capacity to modulate the ATP turnover [6].
In living cells, growth is the result of coupling between
substratecatabolismandmultiplemetabolicprocessestaking
place during net biomass formation and cell maintenance. A
crucial parameter for growth description is its yield, that is,
theeﬃciencyofthetransformationfromsubstrateconsump-
tion to biomass formation. When yeast cells are grown on a
purely respiratory substrate, biomass generation is entirely
connected to substrate oxidation through oxidative phos-
phorylations and, hence, to oxygen consumption. We have
previously shown that, in nonfermentable media, the growth
yield is identical regardless of the strain, growth phase,
and respiratory substrate used [59]. This homeostasis is the
consequence of a strict linear relationship between growth
and respiratory rate. Moreover, the oxygen consumption rate
was strictly controlled by the cellular content in respiratory
chains in such a way that, in vivo, the steady state of oxidative
phosphorylation was kept constant. The cAMP signaling
pathway is now well known to be involved in the regulation
of mitochondrial biogenesis, both in mammalian cells and in
yeast, even though the molecular mechanisms of this process
are not well deﬁned. It has been shown that treatment of
human preadipocytes with forskolin, which leads to an over-
activation of the cAMP pathway, increased mitochondrial
DNA copy number [60]. In yeast, we showed that overacti-
vation of the Ras/cAMP pathway leads to an increase in the
cell mitochondrial content [61, 62]. Yeast has three A kinase
catalytic subunits, which have greater than 75% identity and
areencodedbytheTPK(TPK1,TPK2,andTPK3)genes[63].
Although they are redundant for viability and functions such
as glycogen storage regulation, the three A kinases are not
redundant for other functions [64–66]. We have shown that
in the absence of the yeast protein kinase Tpk3p only, there
is a signiﬁcant decrease in cellular mitochondrial content,
w h e nc e l l sa r eg r o w ni nn o n f e r m e n t a b l em e d i u m[ 67]. This
generates a drastic decrease in cell growth in the Δtpk3c e l l s
versus the wild type cells, since when yeast cells are grown
on respiratory substrate, energy transformation processes
involve oxidative phosphorylation [59].
3.2. The HAP Complex and the Regulation of Mitochondrial
Biogenesis by Redox Agents in the Yeast Saccharomyces cere-
visiae. Similarly to what was shown in mammalian cells,
the ﬁrst identiﬁcation of transcriptional factors regulating
mitochondrial biogenesis in S. cerevisiae resulted from the
study of the regulation of the cytochrome c gene expression
(CYC1). The master regulator of mitochondrial biogenesis
in S. cerevisiae is the HAP complex. It is constituted of four
subunits:Hap2p,Hap3p,Hap4p,andHap5p(Figure 3).Sub-
units 2, 3, and 5 are DNA binding subunits whereas Hap4p
is the activator of the complex [68–72]. As illustrated in
Figure 3, the HAP complex regulates the expression of many
genesencoding proteins involved inmitochondrial functions
[73, 74]. In accordance with that key role, the absence of
any subunits of the HAP complex leads to a growth defect
on nonfermentable medium (i.e., lactate or ethanol). During
growth of Saccharomyces cerevisiae on fermentable medium
(containinghighglucoseconcentration(i.e.,2%(p/v)),there
is a repression of the expression of several genes encoding
mitochondrial proteins [75–77]. Under these conditions, it
has been shown that overexpression of Hap4p, the activator
subunit of the HAP complex, was suﬃcient to derepress
those genes [74, 78]. These results strengthen the main role
played by the HAP complex in the regulation of mitochon-
drial biogenesis. For a long time, the only known signal
regulating the HAP complex was the carbon source. Indeed,
whereas Hap2p, Hap3p, and Hap5p are constitutively
expressed,Hap4pexpressionismaintainedataverylowlevel
duringgrowthonfermentablesubstrates.Growthonnonfer-
mentable substrates strongly induces Hap4p expression and
thus the activity of the HAP complex [71].
As stipulated before, in Δtpk3 cells, there is a decrease
in mitochondrial content. Moreover, in these cells we have
shown that the activity of ROS detoxifying enzymes such as
catalase and superoxide dismutases is strongly induced.
Mitochondria isolated from Δtpk3 cells have a high H2O2
production rate and an elevated level of protein carbonyla-
tion [79]. These results led us to hypothesize that the Δtpk3
cells were subjected to an oxidative stress. Treatment of
Δtpk3 cells with an antioxidant such as NAC, as well as
Sod1p (superoxide dismutase isoform 1) overexpression,
leadstoafullrestorationofgrowth,cellularrespiratoryrates,
and mitochondrial content. This clearly indicates that the
decrease in mitochondrial content of the Δtpk3 cells is due
to an increase in mitochondrial ROS production. In order to
understandthelinkbetweenROSandmitochondrialbiogen-
esis,weassessedHAPcomplexactivityinthesecells.Wewere
abletoshowthatHAPcomplexactivitywasreducedinΔtpk3
cells and restored to the wild type level upon antioxidant
treatment. Moreover, addition to wild type cells of hydrogen
peroxide or antimycin A decreases Hap4p level, the activatorInternational Journal of Cell Biology 5
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Figure 3: The HAP complex: a master regulator of the mitochondrial biogenesis in the yeast Saccharomyces cerevisiae. The four subunits
constituting the complex are represented here. Size diﬀerences illustrate the diﬀerence in the predicted molecular weights of each subunit.
The mitochondrial proteins encoding genes regulated by the complex are also indicated. See text for references.
subunitoftheHAPcomplex[79].Thus,ROSregulatesmito-
chondrial biogenesis in the yeast Saccharomyces cerevisiae
through the regulation of HAP complex activity by decreas-
ing the Hap4p protein level. This work illustrates a mito-
chondrial control-quality process in which the main tran-
scription factors involved in mitochondrial biogenesis are
able to sense a mitochondrial dysfunction and then decrease
the biogenesis of these dysfunctional mitochondria.
Those observations are reinforced by our recent study
linking the glutathione redox state and the mitochondrial
biogenesis. Glutathione is considered as the major redox
buﬀer of the cell because of both its high concentration (1–
10mM) and its low redox potential (Ehc =￿ 240mV) [80,
81]. Reduced glutathione (GSH) is a cosubstrate in many
ROS detoxifying reactions and protein oxidation repairs
(i.e., glutathione peroxidase, glutaredoxins) producing its
oxidized form (GSSG). The glutathione reductase, encoded
by the GLR1 gene in the yeast Saccharomyces cerevisiae,i sa
very important enzyme in the glutathione system because it
regenerates GSH. The deletion of GLR1 leads to a decrease
in the 2GSH/GSSG ratio. In Δglr1 cells growing in non-
fermentable medium, we observed a very low Hap4p level
associatedwithalowmitochondrial content.Theaddition of
reduced glutathione to Δglr1 cells induced an increase in this
ratio and so resulted in a more reduced cell redox state [82].
Undersuchconditions,weshowedthatbothHap4pleveland
mitochondrial content were restored [83].
In 2010, the transcription factor Hcm1p was identiﬁed
as another possible regulator of mitochondrial metabolism
in the yeast Saccharomyces cerevisiae [84]. Indeed, the over-
expression of Hcm1p leads to an increase in the cellular res-
piratory rate and its absence impairs cell growth on ethanol.
Interestingly, the nucleus localization of Hcm1p is increased
by addition of hydrogen peroxide and Hcm1p increases the
expression of antioxidant enzymes such as Sod2p. Thus,
Hcm1p could link mitochondrial biogenesis and the ROS
detoxiﬁcation systems. Although the mechanisms clearly
explaining the link between Hcm1p—formerly known for its
involvement in the regulation of the spindle pole—have not
been shown, this result could represent a novel piece to the
puzzle of the relationship between the oxidative stress and
the regulation of the mitochondrial biogenesis.
4. Conclusion
Due to its dependence on two physically distinct genomes,
the biogenesis of mitochondria has to be a well-coordinated
and regulated process. The identiﬁcation of nuclear tran-
scriptionfactorsregulatingtheexpressionofbothmitochon-
drial and nuclear genes encoding for mitochondrial proteins
was a great advance in that domain. In the landscape of the
regulating signals of the mitochondrial biogenesis, the cellu-
larredoxstateisbecominganimportantactor.Mitochondria
being one of the main sites of ROS production, and many
pathologies being associated with both decrease in mito-
chondrialcontentandoxidativestress,thesestudiesnaturally
raise the question of the crosstalk between the mitochondria
andthenucleus.Bothdecreaseandincreaseofmitochondrial
biogenesis in oxidative conditions have been reported. In
mammalian cells, the tight link between the regulation of
mitochondrial biogenesis and the antioxidant systems has
been mechanistically well described. Thus, it seems logic
that an increase of the mitochondrial biogenesis by ROS
relies on a regulatory system, which is built to prevent the
cell from the ROS production due to increase of the mito-
chondrial metabolism. However, in conditions of excessive
oxidative stress as in the case of some pathologies and/or
severe dysfunction of the mitochondrial respiratory chain, a
decrease in mitochondrial biogenesis could be considered as
a quality-control process through the decrease of dysfunc-
tional mitochondria by ROS. Because of the key roles
played by mitochondria in energy metabolism and many6 International Journal of Cell Biology
other processes, alternative regulatory pathways relying, for
example, on energetic parameters must be taken in consider-
ation. More detailed analyses, notably in regard to the
eventual signal speciﬁcity according to the nature of the
oxidative stress, will certainly be necessary to improve our
understanding of the relationships between the oxidative
stress and the mitochondrial biogenesis process.
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